Niacin And Niacinamide Market

Niacin and Niacinamide Market: Europe will Continue to Lead Global Niacin and Niacinamide Market in Terms of Revenues: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2026)

Ask The Analyst Customization Available Request Methodology

Niacin is an organic compound, and considered to be one of the most essential nutrients for humans, as niacin deficiency causes pellagra. Niacinamide, an amide of niacin, is also referred to as nicotinic acid amide or nicotinamide. Niacin and niacinamide are integral components of Vitamin B3, and are often leveraged as supplements interchangeably. These are commonly found in several food products such as meat, fish, beans, eggs, green vegetables, and yeast. Niacin and niacinamide are also sought in various vitamin supplements, particularly in vitamin B-complex supplements.

Food Fortification Guidelines on Including Niacin and Niacinamide in Majority of Food Products to Propel their Market Growth

Niacin and Niacinamide have been approved by the U.S. Food and Drug Administration for treating patients with pellagra. Over the years, niacin has remained well-recognized for treating individuals with high cholesterols, however recent studies have showcased niacin to have adverse side effects when used to treat cholesterol levels. In countries with malnutrition being one of the major concerns, regulatory bodies are setting up guidelines for food fortification including edible oil, salt, milk, wheat flour, and rice. Inclusion of niacin and niacinamide in majority of these food products is one of the aspects of food fortification in these countries, in order to prevent vitamin B3 deficiency.

niacin and niacinamide market

Deficiency of vitamin B3 leads to development of pellagra. Although pellagra is less prevalent in developed regions on the back of food fortification programs, certain countries in Africa such as Ethiopia, Zaire, and Malawi have a slew of reported cases related to pellagra. A health-conscious trend is fostering across the developed regions, with consumer awareness concerning health benefits of various dietary supplements such as niacin and niacinamide witnessing a rise. In addition, utilization if niacin in the cosmetics, particularly in skin care cosmetics, is gaining huge attraction owing to its ability of protecting skin cells from UV rays.

As projected by Future Market Insights (FMI) in its new research analysis, the global market for niacin and niacinamide will ride on a steady CAGR during the forecast period (2017-2026). Global sales of niacin & niacinamide are estimated to garner roughly US$ 1,500 Mn revenues by 2026-end.

Europe to Lead Global Niacin and Niacinamide Market in Terms of Revenues

Europe will continue to lead the global niacin and niacinamide market, in terms of revenues. Rising incidences of downer cow syndrome (DCS) in dairy cattle, and increasing number of cases related to childhood obesity are prime factors expected to influence demand for niacin & niacinamide in the region. Physical inactivity and unhealthy consumption patterns are main reasons for overweight and obesity in young as well as elder population across European countries, which is becoming a major concern for the region’s healthcare sector. Niacin has potential to enhance adiposity, insulin sensitivity, glucose tolerance, and lipid profile, while modulating adiponectin level, thereby complementing obesity management effectively. Physicians in the region are highly recommending intake of vitamin B3 supplements, such as niacinamide, for tackling complications associated with obesity.

In addition, niacin has been closely linked with improving energy metabolism, and increasing glucose content in cows. Government as well as private institutes in the region are taking initiatives in spreading awareness about niacin’s benefits of preventing and treating DCS and improving milk production in cows among dairy producers.

Key Research Findings from FMI’s Report

  • Powder form of niacin and niacinamide will remain sought-after among consumers, with sales projected to account for over two-third revenue share of the market during 2017 to 2026

  • Animal nutrition is anticipated to remain the largest end-use of niacin and niacinamide across the globe during the forecast period

Competition Tracking

Key players profiled by FMI’s report include Lonza Group AG, Koninklijke DSM N.V., Bactolac Pharmaceutical Inc., Merck KGaA, BASF SE, Foodchem International Corporation, Evonik Industries AG, Jubilant Life Sciences Limited, Vertellus Specialties Inc., Fagron NV, Zhejiang NHU Company Ltd., and Brother Enterprises Holding Co., Ltd.

Future Market Insights (FMI) has composed a new insightful report, titled “Niacin and Niacinamide Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2026)”. The report offers forecasts on global niacin and niacinamide market, examining the market in detail, and providing important dynamics influencing the market expansion. In addition to the provision of intelligence on latest trends, inhibiting factors, and driving factors that impact growth of the market, the report comprises analysis on pertinent data concerning multiple market parameters.

Report Structure

The report’s begins with a chapter on executive summary of the global market for niacin and niacinamide. This chapter issues a summation of the global niacin and niacinamide market along with information about important market numbers, which include historical (2012-2016) and forecast (2017-2026) CAGRs. These market numbers provided are associated with the market segments, particularly form and regional segments. With respect to sales expansion and revenues garnered from worldwide sales of niacin and niacinamide, information about profitable regions for the niacin and niacinamide market’s expansion is contained in the report.

A chapter titled overview of the global niacin and niacinamide market trails behind the executive summary, and incorporates definition of “niacin and niacinamide” that succeeds a succinct market introduction. This chapter clearly portrays the wide scope of the global niacin and niacinamide market. The chapters following the overview shed light on key dynamics impacting demand for niacin and niacinamide globally, and inundates key imperative points such as the bottom line of enterprises, global economy, and fiscal stimulus. In some chapters of the report, information on pricing analysis along with the cost structure of global niacin and niacinamide market has been delivered.

Market Taxonomy

Propagating ahead the report propounds forecasts on global market for niacin and niacinamide via a segmentation analysis. Diving the global market for niacin and niacinamide into three key segments viz. end-use, form, and region, the report offers associated market numbers based on revenue comparison, year-on-year growth comparison, and the market share comparison. The global niacin and niacinamide market is characterized geographically into six key segments - Asia-Pacific excluding Japan (APEJ), North America, Middle East & Africa (MEA), Europe, Latin America, and Japan.

Region

Form

End Use

  • North America

  • Powder

  • Human Nutrition

  • Latin America

  • Granular

  • Pharmaceuticals

  • Europe

  • Liquid

  • Animal Nutrition

  • Japan

 

  • Cosmeceuticals

  • APEJ

 

  • Others

  • MEA

 

 

Competition Landscape

A scrupulous study regarding the global niacin and niacinamide market’s competition landscape is submitted in the ending chapter of this report, which incorporates information about prominent industries contributing to the market growth significantly. Occupancy of key market participants has been tracked with an intensity map. With emphasis on profiling the market participants rigorously, the competition landscape chapter offers Insights based on the SWOT analysis, which illuminates strengths, weaknesses, opportunities, & threats related to the specific market participant. Moreover, information on key developments, company overview, key financials, and product overview appertaining to market players is included in this chapter.

Research Methodology

A research methodology, proven and tested, is used by FMI’s analysts for developing the report on the global niacin and niacinamide market. The research methodology adopted has helped the analysts in providing accurate insights pertaining to the niacin and niacinamide market. This research methodology depends entirely on the primary & secondary researches, for gaining necessary information associate with the global niacin and niacinamide market. The information compiled is then validated several times by the analysts to ensure the authenticity of the report, and for transmuting it into an authoritative reference for the report readers.

Niacin And Niacinamide Market Reports - Table of Contents

Chapter 1 Global Outlook

Chapter 2 Global Niacin and Niacinamide Market - Executive Summary

Chapter 3 Global Niacin and Niacinamide Market Overview

3.1 Introduction

3.1.1 Global Niacin and Niacinamide Market Taxonomy

3.1.2 Global Niacin and Niacinamide Market Definition

3.2 Global Niacin and Niacinamide Market Size (US$ Mn) and Forecast, 2012-2026

3.2.1 Global Niacin and Niacinamide Market Y-o-Y Growth

3.3 Global Niacin and Niacinamide Market Dynamics

3.4 Supply Chain

3.5 Cost Structure

3.6 Pricing Analysis

3.7 Key Regulatory Bodies

3.8 Safety Concerns

3.9 Forecast Factors

3.10 Manufacturing Plant Mapping

3.11 PESTL Analysis

3.12 Product Life Cycle Analysis

3.13 List of Supplier

3.14 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Niacin and Niacinamide Market Analysis and Forecast 2012-2026

4.1 Global Niacin and Niacinamide Market Size and Forecast By Form, 2012-2026

4.1.1 Powder Market Size and Forecast, 2012-2026

4.1.1.1 Revenue (US$ Mn) Comparison, By Region

4.1.1.2 Market Share Comparison, By Region

4.1.1.3 Y-o-Y growth Comparison, By Region

4.1.2 Granular Market Size and Forecast, 2012-2026

4.1.2.1 Revenue (US$ Mn) Comparison, By Region

4.1.2.2 Market Share Comparison, By Region

4.1.2.3 Y-o-Y growth Comparison, By Region

4.1.3 Liquid Market Size and Forecast, 2012-2026

4.1.3.1 Revenue (US$ Mn) Comparison, By Region

4.1.3.2 Market Share Comparison, By Region

4.1.3.3 Y-o-Y growth Comparison, By Region

4.2 Global Niacin and Niacinamide Market Size and Forecast By End Use, 2012-2026

4.2.1 Human Nutrition Market Size and Forecast, 2012-2026

4.2.1.1 Revenue (US$ Mn) Comparison, By Region

4.2.1.2 Market Share Comparison, By Region

4.2.1.3 Y-o-Y growth Comparison, By Region

4.2.2 Pharmaceuticals Market Size and Forecast, 2012-2026

4.2.2.1 Revenue (US$ Mn) Comparison, By Region

4.2.2.2 Market Share Comparison, By Region

4.2.2.3 Y-o-Y growth Comparison, By Region

4.2.3 Animal Nutrition Market Size and Forecast, 2012-2026

4.2.3.1 Revenue (US$ Mn) Comparison, By Region

4.2.3.2 Market Share Comparison, By Region

4.2.3.3 Y-o-Y growth Comparison, By Region

4.2.4 Cosmeceuticals Market Size and Forecast, 2012-2026

4.2.4.1 Revenue (US$ Mn) Comparison, By Region

4.2.4.2 Market Share Comparison, By Region

4.2.4.3 Y-o-Y growth Comparison, By Region

4.2.5 Others Market Size and Forecast, 2012-2026

4.2.5.1 Revenue (US$ Mn) Comparison, By Region

4.2.5.2 Market Share Comparison, By Region

4.2.5.3 Y-o-Y growth Comparison, By Region

Chapter 5 North America Niacin and Niacinamide Market Size and Forecast, 2012-2026

5.1 North America Market Outlook

5.1.1 Political Outlook

5.1.2 Economic Outlook

5.1.3 Business Environment Outlook

5.1.4 North America Healthcare Sector Outlook:

5.1.5 North America Niacin and Niacinamide Market Overlook:

5.2 Revenue (US$ Mn) Comparison, By Country

5.3 Revenue (US$ Mn) Comparison, By Form

5.4 Revenue (US$ Mn) Comparison, By End Use

Chapter 6 Latin America Niacin and Niacinamide Market Size and Forecast, 2012-2026

6.1 Latin America Market Outlook

6.1.1 Political Outlook

6.1.2 Economic Outlook

6.1.3 Business Environment Outlook

6.1.4 Latin America Healthcare Sector Outlook:

6.1.5 Latin America Niacin and Niacinamide Market:

6.2 Revenue (US$ Mn) Comparison, By Country

6.3 Revenue (US$ Mn) Comparison, By Form

6.4 Revenue (US$ Mn) Comparison, By End Use

Chapter 7 Europe Niacin and Niacinamide Market Size and Forecast, 2012-2026

7.1 Europe Market Outlook

7.1.1 Political Outlook

7.1.2 Economic Outlook

7.1.3 Business Environment Outlook

7.1.4 Europe Healthcare Sector Outlook:

7.1.5 Europe Niacin and Niacinamide Market outlook:

7.2 Revenue (US$ Mn) Comparison, By Country

7.3 Revenue (US$ Mn) Comparison, By Form

7.4 Revenue (US$ Mn) Comparison, By End Use

Chapter 8 Japan Niacin and Niacinamide Market Size and Forecast, 2012-2026

8.1 Japan Market Outlook

8.1.1 Political Outlook

8.1.2 Economic Outlook

8.1.3 Business Environment Outlook

8.1.4 Japan Healthcare Sector Outlook:

8.1.5 Japan Niacin and Niacinamide Market Outlook:

8.2 Revenue (US$ Mn) Comparison, By Country

8.3 Revenue (US$ Mn) Comparison, By Form

8.4 Revenue (US$ Mn) Comparison, By End Use

Chapter 9 APEJ Niacin and Niacinamide Market Size and Forecast, 2012-2026

9.1 APEJ Market Outlook

9.1.1 Political Outlook

9.1.2 Economic Outlook

9.1.3 Business Environment Outlook

9.1.4 Asia Pacific Excluding Japan (APEJ) Healthcare Sector Outlook:

9.1.5 Asia Pacific Excluding Japan (APEJ) Niacin and Niacinamide market:

9.2 Revenue (US$ Mn) Comparison, By Country

9.3 Revenue (US$ Mn) Comparison, By Form

9.4 Revenue (US$ Mn) Comparison, By End Use

Chapter 10 MEA Niacin and Niacinamide Market Size and Forecast, 2012-2026

10.1 MEA Market Outlook

10.1.1 Political Outlook

10.1.2 Economic Outlook

10.1.3 Business Environment Outlook

10.1.4 Middle East & Africa (MEA) Healthcare Sector Outlook:

10.1.5 Middle East & Africa (MEA) Niacin and Niacinamide Market Outlook:

10.2 Revenue (US$ Mn) Comparison, By Country

10.3 Revenue (US$ Mn) Comparison, By Form

10.4 Revenue (US$ Mn) Comparison, By End Use

Chapter 11 Global Niacin and Niacinamide Market – Company Share Analysis, Competitive Landscape and Company Profiles

11.1 Global Niacin and Niacinamide Market – Company Share Analysis

11.2 Global Niacin and Niacinamide Market – Competitive Landscape

11.3 Global Niacin and Niacinamide Market – Company Profiles

11.3.1 Lonza Group AG

11.3.1.1 Company Overview

11.3.1.2 Product Overview

11.3.1.3 Key Financials

11.3.1.4 Key Developments

11.3.1.5 SWOT Analysis

11.3.2 Koninklijke DSM N.V.

11.3.2.1 Company Overview

11.3.2.2 Product Overview

11.3.2.3 Key Financials

11.3.2.4 Key Developments

11.3.2.5 SWOT Analysis

11.3.3 Bactolac Pharmaceutical Inc.

11.3.3.1 Company Overview

11.3.3.2 Product Overview

11.3.3.3 Key Developments

11.3.4 Merck KGaA

11.3.4.1 Company Overview

11.3.4.2 Product Overview

11.3.4.3 Key Financials

11.3.4.4 Key Developments

11.3.4.5 SWOT Analysis

11.3.5 BASF SE

11.3.5.1 Company Overview

11.3.5.2 Product Overview

11.3.5.3 Key Financials

11.3.5.4 Key Developments

11.3.5.5 SWOT Analysis

11.3.6 Foodchem International Corporation

11.3.6.1 Company Overview

11.3.6.2 Product Overview

11.3.7 Evonik Industries AG

11.3.7.1 Company Profile

11.3.7.2 Product Overview

11.3.7.3 Key Financials

11.3.7.4 Key Developments

11.3.7.5 SWOT Analysis

11.3.8 Jubilant Life Sciences Limited

11.3.8.1 Company Overview

11.3.8.2 Product Overview

11.3.8.3 Key Financials

11.3.8.4 Key Developments

11.3.9 Vertellus Specialties Inc.

11.3.9.1 Company Overview

11.3.9.2 Product Overview

11.3.10 Fagron NV

11.3.10.1 Company Overview

11.3.10.2 Product Overview

11.3.10.3 Key Financials

11.3.10.4 Key Developments

11.3.11 Zhejiang NHU Company Ltd.

11.3.11.1 Company Overview

11.3.11.2 Product Overview

11.3.11.3 Key Financials

11.3.11.4 Key Developments

11.3.12 Brother Enterprises Holding Co., Ltd.

11.3.12.1 Company Overview

11.3.12.2 Product Overview

11.3.12.3 Key Financials

11.3.12.4 SWOT Analysis

11.4 Key Takeaways

Chapter 12 FMI Research Methodology

Chapter 13 Disclaimer

Niacin And Niacinamide Market Reports - List of Tables

TABLE 1 Global Niacin and Niacinamide Market Value (US$ Mn), 2012-2017

TABLE 2 Global Niacin and Niacinamide Market Value (US$ Mn), 2018-2026

TABLE 3 Global Niacin and Niacinamide Market Value (US$ Mn) and Y-o-Y, 2017-2026

TABLE 4 Global Powder Segment Value (US$ Mn), By Region 2012-2017

TABLE 5 Global Powder Segment Volume (Mt), By Region 2012-2017

TABLE 6 Global Powder Segment Value (US$ Mn), By Region 2018-2026

TABLE 7 Global Powder Segment Volume (Mt), By Region 2018-2026

TABLE 8 Global Powder Segment Market Share, By Region 2012-2017

TABLE 9 Global Powder Segment Market Share, By Region 2018-2026

TABLE 10 Global Powder Segment Y-o-Y, By Region 2017-2026

TABLE 11 Global Granular Segment Value (US$ Mn), By Region 2012-2017

TABLE 12 Global Granular Segment Volume (Mt), By Region 2012-2017

TABLE 13 Global Granular Segment Value (US$ Mn), By Region 2018-2026

TABLE 14 Global Granular Segment Volume (Mt), By Region 2018-2026

TABLE 15 Global Granular Segment Market Share, By Region 2012-2017

TABLE 16 Global Granular Segment Market Share, By Region 2018-2026

TABLE 17 Global Granular Segment Y-o-Y, By Region 2017-2026

TABLE 18 Global Liquid Segment Value (US$ Mn), By Region 2012-2017

TABLE 19 Global Liquid Segment Volume (Mt), By Region 2012-2017

TABLE 20 Global Liquid Segment Value (US$ Mn), By Region 2018-2026

TABLE 21 Global Liquid Segment Volume (Mt), By Region 2018-2026

TABLE 22 Global Liquid Segment Market Share, By Region 2012-2017

TABLE 23 Global Liquid Segment Market Share, By Region 2018-2026

TABLE 24 Global Liquid Segment Y-o-Y, By Region 2017-2026

TABLE 25 Global Human Nutrition Segment Value (US$ Mn), By Region 2012-2017

TABLE 26 Global Human Nutrition Segment Volume (Mt), By Region 2012-2017

TABLE 27 Global Human Nutrition Segment Value (US$ Mn), By Region 2018-2026

TABLE 28 Global Human Nutrition Segment Volume (Mt), By Region 2018-2026

TABLE 29 Global Human Nutrition Segment Market Share, By Region 2012-2017

TABLE 30 Global Human Nutrition Segment Market Share, By Region 2018-2026

TABLE 31 Global Human Nutrition Segment Y-o-Y, By Region 2017-2026

TABLE 32 Global Pharmaceuticals Segment Value (US$ Mn), By Region 2012-2017

TABLE 33 Global Pharmaceuticals Segment Volume (Mt), By Region 2012-2017

TABLE 34 Global Pharmaceuticals Segment Value (US$ Mn), By Region 2018-2026

TABLE 35 Global Pharmaceuticals Segment Volume (Mt), By Region 2018-2026

TABLE 36 Global Pharmaceuticals Segment Market Share, By Region 2012-2017

TABLE 37 Global Pharmaceuticals Segment Market Share, By Region 2018-2026

TABLE 38 Global Pharmaceuticals Segment Y-o-Y, By Region 2017-2026

TABLE 39 Global Animal Nutrition Segment Value (US$ Mn), By Region 2012-2017

TABLE 40 Global Animal Nutrition Segment Volume (Mt), By Region 2012-2017

TABLE 41 Global Animal Nutrition Segment Value (US$ Mn), By Region 2018-2026

TABLE 42 Global Animal Nutrition Segment Volume (Mt), By Region 2018-2026

TABLE 43 Global Animal Nutrition Segment Market Share, By Region 2012-2017

TABLE 44 Global Animal Nutrition Segment Market Share, By Region 2018-2026

TABLE 45 Global Animal Nutrition Segment Y-o-Y, By Region 2017-2026

TABLE 46 Global Cosmeceuticals Segment Value (US$ Mn), By Region 2012-2017

TABLE 47 Global Cosmeceuticals Segment Volume (Mt), By Region 2012-2017

TABLE 48 Global Cosmeceuticals Segment Value (US$ Mn), By Region 2018-2026

TABLE 49 Global Cosmeceuticals Segment Volume (Mt), By Region 2018-2026

TABLE 50 Global Cosmeceuticals Segment Market Share, By Region 2012-2017

TABLE 51 Global Cosmeceuticals Segment Market Share, By Region 2018-2026

TABLE 52 Global Cosmeceuticals Segment Y-o-Y, By Region 2017-2026

TABLE 53 Global Others Segment Value (US$ Mn), By Region 2012-2017

TABLE 54 Global Others Segment Volume (Mt), By Region 2012-2017

TABLE 55 Global Others Segment Value (US$ Mn), By Region 2018-2026

TABLE 56 Global Others Segment Volume (Mt), By Region 2018-2026

TABLE 57 Global Others Segment Market Share, By Region 2012-2017

TABLE 58 Global Others Segment Market Share, By Region 2018-2026

TABLE 59 Global Others Segment Y-o-Y, By Region 2017-2026

TABLE 60 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 61 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 62 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 63 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 64 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 65 North America Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

TABLE 66 North America Niacin and Niacinamide Market Volume (Mt), By Country 2012-2017

TABLE 67 North America Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

TABLE 68 North America Niacin and Niacinamide Market Volume (Mt), By Country 2018-2026

TABLE 69 North America Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

TABLE 70 North America Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

TABLE 71 North America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

TABLE 72 North America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

TABLE 73 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 74 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 75 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 76 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 77 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 78 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

TABLE 79 Latin America Niacin and Niacinamide Market Volume (Mt), By Country 2012-2017

TABLE 80 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

TABLE 81 Latin America Niacin and Niacinamide Market Volume (Mt), By Country 2018-2026

TABLE 82 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

TABLE 83 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

TABLE 84 Latin America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

TABLE 85 Latin America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

TABLE 86 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 87 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 88 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 89 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 90 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 91 Europe Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

TABLE 92 Europe Niacin and Niacinamide Market Volume (Mt), By Country 2012-2017

TABLE 93 Europe Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

TABLE 94 Europe Niacin and Niacinamide Market Volume (Mt), By Country 2018-2026

TABLE 95 Europe Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

TABLE 96 Europe Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

TABLE 97 Europe Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

TABLE 98 Europe Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

TABLE 99 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 100 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 101 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 102 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 103 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 104 Japan Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

TABLE 105 Japan Niacin and Niacinamide Market Volume (Mt), By Country 2012-2017

TABLE 106 Japan Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

TABLE 107 Japan Niacin and Niacinamide Market Volume (Mt), By Country 2018-2026

TABLE 108 Japan Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

TABLE 109 Japan Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

TABLE 110 Japan Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

TABLE 111 Japan Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

TABLE 112 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 113 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 114 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 115 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 116 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 117 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

TABLE 118 APEJ Niacin and Niacinamide Market Volume (Mt), By Country 2012-2017

TABLE 119 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

TABLE 120 APEJ Niacin and Niacinamide Market Volume (Mt), By Country 2018-2026

TABLE 121 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

TABLE 122 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

TABLE 123 APEJ Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

TABLE 124 APEJ Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

TABLE 125 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 126 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 127 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 128 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 129 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 130 MEA Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

TABLE 131 MEA Niacin and Niacinamide Market Volume (Mt), By Country 2012-2017

TABLE 132 MEA Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

TABLE 133 MEA Niacin and Niacinamide Market Volume (Mt), By Country 2018-2026

TABLE 134 MEA Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

TABLE 135 MEA Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

TABLE 136 MEA Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

TABLE 137 MEA Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

Niacin And Niacinamide Market Reports - List of Figures

FIG. 1 Global Niacin and Niacinamide Market Value (US$ Mn), 2012-2017

FIG. 2 Global Niacin and Niacinamide Market Value (US$ Mn) Forecast, 2018-2026

FIG. 3 Global Niacin and Niacinamide Market Value (US$ Mn) and Y-o-Y, 2017-2026

FIG. 4 Global Powder Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 5 Global Powder Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 6 Global Powder Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 7 Global Granular Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 8 Global Granular Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 9 Global Granular Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 10 Global Liquid Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 11 Global Liquid Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 12 Global Liquid Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 13 Global Human Nutrition Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 14 Global Human Nutrition Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 15 Global Human Nutrition Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 16 Global Pharmaceuticals Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 17 Global Pharmaceuticals Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 18 Global Pharmaceuticals Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 19 Global Animal Nutrition Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 20 Global Animal Nutrition Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 21 Global Animal Nutrition Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 22 Global Cosmeceuticals Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 23 Global Cosmeceuticals Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 24 Global Cosmeceuticals Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 25 Global Others Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 26 Global Others Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 27 Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 28 North America Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

FIG. 29 North America Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

FIG. 30 North America Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

FIG. 31 North America Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

FIG. 32 North America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

FIG. 33 North America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

FIG. 34 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

FIG. 35 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

FIG. 36 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

FIG. 37 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

FIG. 38 Latin America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

FIG. 39 Latin America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

FIG. 40 Europe Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

FIG. 41 Europe Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

FIG. 42 Europe Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

FIG. 43 Europe Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

FIG. 44 Europe Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

FIG. 45 Europe Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

FIG. 46 Japan Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

FIG. 47 Japan Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

FIG. 48 Japan Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

FIG. 49 Japan Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

FIG. 50 Japan Niacin and Niacinamide Market Value (US$ Mn), By 2012-2017

FIG. 51 Japan Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

FIG. 52 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

FIG. 53 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

FIG. 54 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

FIG. 55 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

FIG. 56 APEJ Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

FIG. 57 APEJ Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026

FIG. 58 MEA Niacin and Niacinamide Market Value (US$ Mn), By Country 2012-2017

FIG. 59 MEA Niacin and Niacinamide Market Value (US$ Mn), By Country 2018-2026

FIG. 60 MEA Niacin and Niacinamide Market Value (US$ Mn), By Form 2012-2017

FIG. 61 MEA Niacin and Niacinamide Market Value (US$ Mn), By Form 2018-2026

FIG. 62 MEA Niacin and Niacinamide Market Value (US$ Mn), By End Use 2012-2017

FIG. 63 MEA Niacin and Niacinamide Market Value (US$ Mn), By End Use 2018-2026